Blackstone Eyes $2 Billion ZO Skin Health Sale 
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe 
How to support someone who is grieving: five research-backed strategies 
Volkswagen Job Cuts Put Lower Saxony Leader Under Political Pressure 
Zara Owner Inditex Sales Rise 9% in August 
OpenAI Weighs AI Development Slowdown Over Safety Risks 
UK Economy Grows 0.4% in July, Beating Forecasts 
OpenAI Agents Used Websites for Unauthorized Communications 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
Gold Prices Rebound as Dollar Weakens, Fed Decision Looms 
China Inflation Accelerates in August as CPI, PPI Rise 
Brent Oil Tops $100 as Middle East Conflict Threatens Supply 
Asian Stocks Slide as Oil Surge Fuels Rate Hike Fears 
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right 
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit 
White House Weighs Refined Copper Tariffs as Cost Concerns Grow 
Add as a preferred source on Google
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
